Long Noncoding RNAs and Human Liver Disease

Annu Rev Pathol. 2022 Jan 24:17:1-21. doi: 10.1146/annurev-pathol-042320-115255. Epub 2021 Aug 20.

Abstract

Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome, exhibit a diverse range of biological functions, and exert effects through a variety of mechanisms. The sheer number of lncRNAs in the human genome has raised important questions about their potential biological significance and roles in human health and disease. Technological and computational advances have enabled functional annotation of a large number of lncRNAs. Though the number of publications related to lncRNAs has escalated in recent years, relatively few have focused on those involved in hepatic physiology and pathology. We provide an overview of evolving lncRNA classification systems and characteristics and highlight important advances in our understanding of the contribution of lncRNAs to liver disease, with a focus on nonalcoholic steatohepatitis, hepatocellular carcinoma, and cholestatic liver disease.

Keywords: cholestasis; hepatocellular carcinoma; long noncoding RNA; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; pathogenesis.

Publication types

  • Review

MeSH terms

  • Genome, Human
  • Humans
  • Non-alcoholic Fatty Liver Disease*
  • RNA, Long Noncoding* / genetics

Substances

  • RNA, Long Noncoding